We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MSCI:NYSEMSCI Inc. Analysis

Data as of 2026-06-12 - not real-time

$594.31

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

MSCI is trading comfortably above its short‑term moving average while still under its longer‑term averages, indicating a bullish trend despite a recent bearish MACD crossover and a neutral RSI. The stock carries a premium valuation, with a price‑to‑earnings multiple well above the industry average and a discounted‑cash‑flow model suggesting a sizeable downside. Fundamental metrics remain strong – revenue is growing, margins are robust, and cash flow comfortably covers the dividend, which is supported by a moderate payout ratio. Analyst sentiment leans toward a buy recommendation, driven by growth opportunities in ESG data, ETF indexing, and private‑capital solutions, but the current price reflects high market optimism.
Investors should weigh the near‑term technical weakness and valuation premium against the company’s solid earnings profile and sustainable dividend, positioning MSCI as a hold in the short run with upside potential if valuation compresses over the medium to long term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram indicating potential near‑term weakness
  • Price approaching a strong resistance level
  • Neutral RSI suggesting limited upside momentum

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustained revenue growth and high operating margins
  • Analyst consensus of buy backed by strong earnings outlook
  • Valuation premium that may require price correction before upside

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Expanding ESG and climate data services aligning with regulatory trends
  • Growing ETF and private‑capital markets driving recurring revenue
  • Solid cash flow generation supporting dividend sustainability and potential reinvestment

Key Metrics & Analysis

Financial Health

Revenue Growth14.10%
Profit Margin40.74%
P/E Ratio33.9
ROA20.55%
P/B Ratio-15.6
Op. Cash Flow$1.6B
Free Cash Flow$1.2B
Industry P/E16.6

Technical Analysis

TrendBullish
RSI47.6
Support$558.47
Resistance$644.68
MA 20$601.57
MA 50$584.42
MA 200$568.47
MACDBearish
VolumeStable
Fear & Greed Index86.71

Valuation

Fair Value$304.23
Target Price$688.56
Upside/Downside15.86%
GradeOvervalued
TypeGrowth
Dividend Yield1.38%

Risk Assessment

Beta0.51
Volatility25.68%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.